Global Next-Generation Immunology Drugs Supply, Demand and Key Producers, 2023-2029
The global Next-Generation Immunology Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Next-Generation Immunology Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Next-Generation Immunology Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next-Generation Immunology Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Next-Generation Immunology Drugs total market, 2018-2029, (USD Million)
Global Next-Generation Immunology Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Next-Generation Immunology Drugs total market, key domestic companies and share, (USD Million)
Global Next-Generation Immunology Drugs revenue by player and market share 2018-2023, (USD Million)
Global Next-Generation Immunology Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Next-Generation Immunology Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Next-Generation Immunology Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc, Abbvie Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Amgen Inc., Novartis AG, Astellas Pharma Inc., Bristol-Myers Squibb Company and Merck & Co., Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Next-Generation Immunology Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Next-Generation Immunology Drugs Market, By Region:
1. How big is the global Next-Generation Immunology Drugs market?
2. What is the demand of the global Next-Generation Immunology Drugs market?
3. What is the year over year growth of the global Next-Generation Immunology Drugs market?
4. What is the total value of the global Next-Generation Immunology Drugs market?
5. Who are the major players in the global Next-Generation Immunology Drugs market?
6. What are the growth factors driving the market demand?
This report studies the global Next-Generation Immunology Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Next-Generation Immunology Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next-Generation Immunology Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Next-Generation Immunology Drugs total market, 2018-2029, (USD Million)
Global Next-Generation Immunology Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Next-Generation Immunology Drugs total market, key domestic companies and share, (USD Million)
Global Next-Generation Immunology Drugs revenue by player and market share 2018-2023, (USD Million)
Global Next-Generation Immunology Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Next-Generation Immunology Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Next-Generation Immunology Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc, Abbvie Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Amgen Inc., Novartis AG, Astellas Pharma Inc., Bristol-Myers Squibb Company and Merck & Co., Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Next-Generation Immunology Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Next-Generation Immunology Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cell Therapy
- Small Molecule Drug
- Others
- Hospital
- Clinic
- Others
- Pfizer Inc
- Abbvie Inc.
- Johnson and Johnson
- F. Hoffmann-La Roche Ltd.
- Amgen Inc.
- Novartis AG
- Astellas Pharma Inc.
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- Eli Lilly and Company
1. How big is the global Next-Generation Immunology Drugs market?
2. What is the demand of the global Next-Generation Immunology Drugs market?
3. What is the year over year growth of the global Next-Generation Immunology Drugs market?
4. What is the total value of the global Next-Generation Immunology Drugs market?
5. Who are the major players in the global Next-Generation Immunology Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Next-Generation Immunology Drugs Introduction
1.2 World Next-Generation Immunology Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Next-Generation Immunology Drugs Total Market by Region (by Headquarter Location)
1.3.1 World Next-Generation Immunology Drugs Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Next-Generation Immunology Drugs Market Size (2018-2029)
1.3.3 China Next-Generation Immunology Drugs Market Size (2018-2029)
1.3.4 Europe Next-Generation Immunology Drugs Market Size (2018-2029)
1.3.5 Japan Next-Generation Immunology Drugs Market Size (2018-2029)
1.3.6 South Korea Next-Generation Immunology Drugs Market Size (2018-2029)
1.3.7 ASEAN Next-Generation Immunology Drugs Market Size (2018-2029)
1.3.8 India Next-Generation Immunology Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Next-Generation Immunology Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Next-Generation Immunology Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.2 World Next-Generation Immunology Drugs Consumption Value by Region
2.2.1 World Next-Generation Immunology Drugs Consumption Value by Region (2018-2023)
2.2.2 World Next-Generation Immunology Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.4 China Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.5 Europe Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.6 Japan Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.7 South Korea Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.8 ASEAN Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.9 India Next-Generation Immunology Drugs Consumption Value (2018-2029)
3 WORLD NEXT-GENERATION IMMUNOLOGY DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Next-Generation Immunology Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Next-Generation Immunology Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Next-Generation Immunology Drugs in 2022
3.2.3 Global Concentration Ratios (CR8) for Next-Generation Immunology Drugs in 2022
3.3 Next-Generation Immunology Drugs Company Evaluation Quadrant
3.4 Next-Generation Immunology Drugs Market: Overall Company Footprint Analysis
3.4.1 Next-Generation Immunology Drugs Market: Region Footprint
3.4.2 Next-Generation Immunology Drugs Market: Company Product Type Footprint
3.4.3 Next-Generation Immunology Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Next-Generation Immunology Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Next-Generation Immunology Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Next-Generation Immunology Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Next-Generation Immunology Drugs Consumption Value Comparison
4.2.1 United States VS China: Next-Generation Immunology Drugs Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Next-Generation Immunology Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Next-Generation Immunology Drugs Companies and Market Share, 2018-2023
4.3.1 United States Based Next-Generation Immunology Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Next-Generation Immunology Drugs Revenue, (2018-2023)
4.4 China Based Companies Next-Generation Immunology Drugs Revenue and Market Share, 2018-2023
4.4.1 China Based Next-Generation Immunology Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Next-Generation Immunology Drugs Revenue, (2018-2023)
4.5 Rest of World Based Next-Generation Immunology Drugs Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Next-Generation Immunology Drugs Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Next-Generation Immunology Drugs Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Next-Generation Immunology Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Cell Therapy
5.2.2 Small Molecule Drug
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Next-Generation Immunology Drugs Market Size by Type (2018-2023)
5.3.2 World Next-Generation Immunology Drugs Market Size by Type (2024-2029)
5.3.3 World Next-Generation Immunology Drugs Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Next-Generation Immunology Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Next-Generation Immunology Drugs Market Size by Application (2018-2023)
6.3.2 World Next-Generation Immunology Drugs Market Size by Application (2024-2029)
6.3.3 World Next-Generation Immunology Drugs Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer Inc
7.1.1 Pfizer Inc Details
7.1.2 Pfizer Inc Major Business
7.1.3 Pfizer Inc Next-Generation Immunology Drugs Product and Services
7.1.4 Pfizer Inc Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Inc Recent Developments/Updates
7.1.6 Pfizer Inc Competitive Strengths & Weaknesses
7.2 Abbvie Inc.
7.2.1 Abbvie Inc. Details
7.2.2 Abbvie Inc. Major Business
7.2.3 Abbvie Inc. Next-Generation Immunology Drugs Product and Services
7.2.4 Abbvie Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abbvie Inc. Recent Developments/Updates
7.2.6 Abbvie Inc. Competitive Strengths & Weaknesses
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Details
7.3.2 Johnson and Johnson Major Business
7.3.3 Johnson and Johnson Next-Generation Immunology Drugs Product and Services
7.3.4 Johnson and Johnson Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Johnson and Johnson Recent Developments/Updates
7.3.6 Johnson and Johnson Competitive Strengths & Weaknesses
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 F. Hoffmann-La Roche Ltd. Details
7.4.2 F. Hoffmann-La Roche Ltd. Major Business
7.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product and Services
7.4.4 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
7.4.6 F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
7.5 Amgen Inc.
7.5.1 Amgen Inc. Details
7.5.2 Amgen Inc. Major Business
7.5.3 Amgen Inc. Next-Generation Immunology Drugs Product and Services
7.5.4 Amgen Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Amgen Inc. Recent Developments/Updates
7.5.6 Amgen Inc. Competitive Strengths & Weaknesses
7.6 Novartis AG
7.6.1 Novartis AG Details
7.6.2 Novartis AG Major Business
7.6.3 Novartis AG Next-Generation Immunology Drugs Product and Services
7.6.4 Novartis AG Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Novartis AG Recent Developments/Updates
7.6.6 Novartis AG Competitive Strengths & Weaknesses
7.7 Astellas Pharma Inc.
7.7.1 Astellas Pharma Inc. Details
7.7.2 Astellas Pharma Inc. Major Business
7.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Product and Services
7.7.4 Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Astellas Pharma Inc. Recent Developments/Updates
7.7.6 Astellas Pharma Inc. Competitive Strengths & Weaknesses
7.8 Bristol-Myers Squibb Company
7.8.1 Bristol-Myers Squibb Company Details
7.8.2 Bristol-Myers Squibb Company Major Business
7.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product and Services
7.8.4 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.8.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.9 Merck & Co., Inc.
7.9.1 Merck & Co., Inc. Details
7.9.2 Merck & Co., Inc. Major Business
7.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Product and Services
7.9.4 Merck & Co., Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Merck & Co., Inc. Recent Developments/Updates
7.9.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Details
7.10.2 Eli Lilly and Company Major Business
7.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Product and Services
7.10.4 Eli Lilly and Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Eli Lilly and Company Recent Developments/Updates
7.10.6 Eli Lilly and Company Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Next-Generation Immunology Drugs Industry Chain
8.2 Next-Generation Immunology Drugs Upstream Analysis
8.3 Next-Generation Immunology Drugs Midstream Analysis
8.4 Next-Generation Immunology Drugs Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Next-Generation Immunology Drugs Introduction
1.2 World Next-Generation Immunology Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Next-Generation Immunology Drugs Total Market by Region (by Headquarter Location)
1.3.1 World Next-Generation Immunology Drugs Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Next-Generation Immunology Drugs Market Size (2018-2029)
1.3.3 China Next-Generation Immunology Drugs Market Size (2018-2029)
1.3.4 Europe Next-Generation Immunology Drugs Market Size (2018-2029)
1.3.5 Japan Next-Generation Immunology Drugs Market Size (2018-2029)
1.3.6 South Korea Next-Generation Immunology Drugs Market Size (2018-2029)
1.3.7 ASEAN Next-Generation Immunology Drugs Market Size (2018-2029)
1.3.8 India Next-Generation Immunology Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Next-Generation Immunology Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Next-Generation Immunology Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.2 World Next-Generation Immunology Drugs Consumption Value by Region
2.2.1 World Next-Generation Immunology Drugs Consumption Value by Region (2018-2023)
2.2.2 World Next-Generation Immunology Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.4 China Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.5 Europe Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.6 Japan Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.7 South Korea Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.8 ASEAN Next-Generation Immunology Drugs Consumption Value (2018-2029)
2.9 India Next-Generation Immunology Drugs Consumption Value (2018-2029)
3 WORLD NEXT-GENERATION IMMUNOLOGY DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Next-Generation Immunology Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Next-Generation Immunology Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Next-Generation Immunology Drugs in 2022
3.2.3 Global Concentration Ratios (CR8) for Next-Generation Immunology Drugs in 2022
3.3 Next-Generation Immunology Drugs Company Evaluation Quadrant
3.4 Next-Generation Immunology Drugs Market: Overall Company Footprint Analysis
3.4.1 Next-Generation Immunology Drugs Market: Region Footprint
3.4.2 Next-Generation Immunology Drugs Market: Company Product Type Footprint
3.4.3 Next-Generation Immunology Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Next-Generation Immunology Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Next-Generation Immunology Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Next-Generation Immunology Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Next-Generation Immunology Drugs Consumption Value Comparison
4.2.1 United States VS China: Next-Generation Immunology Drugs Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Next-Generation Immunology Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Next-Generation Immunology Drugs Companies and Market Share, 2018-2023
4.3.1 United States Based Next-Generation Immunology Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Next-Generation Immunology Drugs Revenue, (2018-2023)
4.4 China Based Companies Next-Generation Immunology Drugs Revenue and Market Share, 2018-2023
4.4.1 China Based Next-Generation Immunology Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Next-Generation Immunology Drugs Revenue, (2018-2023)
4.5 Rest of World Based Next-Generation Immunology Drugs Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Next-Generation Immunology Drugs Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Next-Generation Immunology Drugs Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Next-Generation Immunology Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Cell Therapy
5.2.2 Small Molecule Drug
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Next-Generation Immunology Drugs Market Size by Type (2018-2023)
5.3.2 World Next-Generation Immunology Drugs Market Size by Type (2024-2029)
5.3.3 World Next-Generation Immunology Drugs Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Next-Generation Immunology Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Next-Generation Immunology Drugs Market Size by Application (2018-2023)
6.3.2 World Next-Generation Immunology Drugs Market Size by Application (2024-2029)
6.3.3 World Next-Generation Immunology Drugs Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer Inc
7.1.1 Pfizer Inc Details
7.1.2 Pfizer Inc Major Business
7.1.3 Pfizer Inc Next-Generation Immunology Drugs Product and Services
7.1.4 Pfizer Inc Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Inc Recent Developments/Updates
7.1.6 Pfizer Inc Competitive Strengths & Weaknesses
7.2 Abbvie Inc.
7.2.1 Abbvie Inc. Details
7.2.2 Abbvie Inc. Major Business
7.2.3 Abbvie Inc. Next-Generation Immunology Drugs Product and Services
7.2.4 Abbvie Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abbvie Inc. Recent Developments/Updates
7.2.6 Abbvie Inc. Competitive Strengths & Weaknesses
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Details
7.3.2 Johnson and Johnson Major Business
7.3.3 Johnson and Johnson Next-Generation Immunology Drugs Product and Services
7.3.4 Johnson and Johnson Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Johnson and Johnson Recent Developments/Updates
7.3.6 Johnson and Johnson Competitive Strengths & Weaknesses
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 F. Hoffmann-La Roche Ltd. Details
7.4.2 F. Hoffmann-La Roche Ltd. Major Business
7.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product and Services
7.4.4 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
7.4.6 F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
7.5 Amgen Inc.
7.5.1 Amgen Inc. Details
7.5.2 Amgen Inc. Major Business
7.5.3 Amgen Inc. Next-Generation Immunology Drugs Product and Services
7.5.4 Amgen Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Amgen Inc. Recent Developments/Updates
7.5.6 Amgen Inc. Competitive Strengths & Weaknesses
7.6 Novartis AG
7.6.1 Novartis AG Details
7.6.2 Novartis AG Major Business
7.6.3 Novartis AG Next-Generation Immunology Drugs Product and Services
7.6.4 Novartis AG Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Novartis AG Recent Developments/Updates
7.6.6 Novartis AG Competitive Strengths & Weaknesses
7.7 Astellas Pharma Inc.
7.7.1 Astellas Pharma Inc. Details
7.7.2 Astellas Pharma Inc. Major Business
7.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Product and Services
7.7.4 Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Astellas Pharma Inc. Recent Developments/Updates
7.7.6 Astellas Pharma Inc. Competitive Strengths & Weaknesses
7.8 Bristol-Myers Squibb Company
7.8.1 Bristol-Myers Squibb Company Details
7.8.2 Bristol-Myers Squibb Company Major Business
7.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product and Services
7.8.4 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.8.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.9 Merck & Co., Inc.
7.9.1 Merck & Co., Inc. Details
7.9.2 Merck & Co., Inc. Major Business
7.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Product and Services
7.9.4 Merck & Co., Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Merck & Co., Inc. Recent Developments/Updates
7.9.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Details
7.10.2 Eli Lilly and Company Major Business
7.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Product and Services
7.10.4 Eli Lilly and Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Eli Lilly and Company Recent Developments/Updates
7.10.6 Eli Lilly and Company Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Next-Generation Immunology Drugs Industry Chain
8.2 Next-Generation Immunology Drugs Upstream Analysis
8.3 Next-Generation Immunology Drugs Midstream Analysis
8.4 Next-Generation Immunology Drugs Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Next-Generation Immunology Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Next-Generation Immunology Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Next-Generation Immunology Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Next-Generation Immunology Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Next-Generation Immunology Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Next-Generation Immunology Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Next-Generation Immunology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Next-Generation Immunology Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Next-Generation Immunology Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Next-Generation Immunology Drugs Players in 2022
Table 12. World Next-Generation Immunology Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Next-Generation Immunology Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Next-Generation Immunology Drugs Player
Table 15. Next-Generation Immunology Drugs Market: Company Product Type Footprint
Table 16. Next-Generation Immunology Drugs Market: Company Product Application Footprint
Table 17. Next-Generation Immunology Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Next-Generation Immunology Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Next-Generation Immunology Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Next-Generation Immunology Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Next-Generation Immunology Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Next-Generation Immunology Drugs Revenue Market Share (2018-2023)
Table 23. China Based Next-Generation Immunology Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Next-Generation Immunology Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Next-Generation Immunology Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Next-Generation Immunology Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Next-Generation Immunology Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Next-Generation Immunology Drugs Revenue Market Share (2018-2023)
Table 29. World Next-Generation Immunology Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Next-Generation Immunology Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Next-Generation Immunology Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Next-Generation Immunology Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Next-Generation Immunology Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World Next-Generation Immunology Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Pfizer Inc Basic Information, Area Served and Competitors
Table 36. Pfizer Inc Major Business
Table 37. Pfizer Inc Next-Generation Immunology Drugs Product and Services
Table 38. Pfizer Inc Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pfizer Inc Recent Developments/Updates
Table 40. Pfizer Inc Competitive Strengths & Weaknesses
Table 41. Abbvie Inc. Basic Information, Area Served and Competitors
Table 42. Abbvie Inc. Major Business
Table 43. Abbvie Inc. Next-Generation Immunology Drugs Product and Services
Table 44. Abbvie Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abbvie Inc. Recent Developments/Updates
Table 46. Abbvie Inc. Competitive Strengths & Weaknesses
Table 47. Johnson and Johnson Basic Information, Area Served and Competitors
Table 48. Johnson and Johnson Major Business
Table 49. Johnson and Johnson Next-Generation Immunology Drugs Product and Services
Table 50. Johnson and Johnson Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Johnson and Johnson Recent Developments/Updates
Table 52. Johnson and Johnson Competitive Strengths & Weaknesses
Table 53. F. Hoffmann-La Roche Ltd. Basic Information, Area Served and Competitors
Table 54. F. Hoffmann-La Roche Ltd. Major Business
Table 55. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product and Services
Table 56. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 58. F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 59. Amgen Inc. Basic Information, Area Served and Competitors
Table 60. Amgen Inc. Major Business
Table 61. Amgen Inc. Next-Generation Immunology Drugs Product and Services
Table 62. Amgen Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Amgen Inc. Recent Developments/Updates
Table 64. Amgen Inc. Competitive Strengths & Weaknesses
Table 65. Novartis AG Basic Information, Area Served and Competitors
Table 66. Novartis AG Major Business
Table 67. Novartis AG Next-Generation Immunology Drugs Product and Services
Table 68. Novartis AG Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Novartis AG Recent Developments/Updates
Table 70. Novartis AG Competitive Strengths & Weaknesses
Table 71. Astellas Pharma Inc. Basic Information, Area Served and Competitors
Table 72. Astellas Pharma Inc. Major Business
Table 73. Astellas Pharma Inc. Next-Generation Immunology Drugs Product and Services
Table 74. Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Astellas Pharma Inc. Recent Developments/Updates
Table 76. Astellas Pharma Inc. Competitive Strengths & Weaknesses
Table 77. Bristol-Myers Squibb Company Basic Information, Area Served and Competitors
Table 78. Bristol-Myers Squibb Company Major Business
Table 79. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product and Services
Table 80. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Bristol-Myers Squibb Company Recent Developments/Updates
Table 82. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 83. Merck & Co., Inc. Basic Information, Area Served and Competitors
Table 84. Merck & Co., Inc. Major Business
Table 85. Merck & Co., Inc. Next-Generation Immunology Drugs Product and Services
Table 86. Merck & Co., Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Merck & Co., Inc. Recent Developments/Updates
Table 88. Eli Lilly and Company Basic Information, Area Served and Competitors
Table 89. Eli Lilly and Company Major Business
Table 90. Eli Lilly and Company Next-Generation Immunology Drugs Product and Services
Table 91. Eli Lilly and Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Next-Generation Immunology Drugs Upstream (Raw Materials)
Table 93. Next-Generation Immunology Drugs Typical Customers
Table 1. World Next-Generation Immunology Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Next-Generation Immunology Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Next-Generation Immunology Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Next-Generation Immunology Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Next-Generation Immunology Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Next-Generation Immunology Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Next-Generation Immunology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Next-Generation Immunology Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Next-Generation Immunology Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Next-Generation Immunology Drugs Players in 2022
Table 12. World Next-Generation Immunology Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Next-Generation Immunology Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Next-Generation Immunology Drugs Player
Table 15. Next-Generation Immunology Drugs Market: Company Product Type Footprint
Table 16. Next-Generation Immunology Drugs Market: Company Product Application Footprint
Table 17. Next-Generation Immunology Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Next-Generation Immunology Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Next-Generation Immunology Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Next-Generation Immunology Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Next-Generation Immunology Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Next-Generation Immunology Drugs Revenue Market Share (2018-2023)
Table 23. China Based Next-Generation Immunology Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Next-Generation Immunology Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Next-Generation Immunology Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Next-Generation Immunology Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Next-Generation Immunology Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Next-Generation Immunology Drugs Revenue Market Share (2018-2023)
Table 29. World Next-Generation Immunology Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Next-Generation Immunology Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Next-Generation Immunology Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Next-Generation Immunology Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Next-Generation Immunology Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World Next-Generation Immunology Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Pfizer Inc Basic Information, Area Served and Competitors
Table 36. Pfizer Inc Major Business
Table 37. Pfizer Inc Next-Generation Immunology Drugs Product and Services
Table 38. Pfizer Inc Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pfizer Inc Recent Developments/Updates
Table 40. Pfizer Inc Competitive Strengths & Weaknesses
Table 41. Abbvie Inc. Basic Information, Area Served and Competitors
Table 42. Abbvie Inc. Major Business
Table 43. Abbvie Inc. Next-Generation Immunology Drugs Product and Services
Table 44. Abbvie Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abbvie Inc. Recent Developments/Updates
Table 46. Abbvie Inc. Competitive Strengths & Weaknesses
Table 47. Johnson and Johnson Basic Information, Area Served and Competitors
Table 48. Johnson and Johnson Major Business
Table 49. Johnson and Johnson Next-Generation Immunology Drugs Product and Services
Table 50. Johnson and Johnson Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Johnson and Johnson Recent Developments/Updates
Table 52. Johnson and Johnson Competitive Strengths & Weaknesses
Table 53. F. Hoffmann-La Roche Ltd. Basic Information, Area Served and Competitors
Table 54. F. Hoffmann-La Roche Ltd. Major Business
Table 55. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product and Services
Table 56. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 58. F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 59. Amgen Inc. Basic Information, Area Served and Competitors
Table 60. Amgen Inc. Major Business
Table 61. Amgen Inc. Next-Generation Immunology Drugs Product and Services
Table 62. Amgen Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Amgen Inc. Recent Developments/Updates
Table 64. Amgen Inc. Competitive Strengths & Weaknesses
Table 65. Novartis AG Basic Information, Area Served and Competitors
Table 66. Novartis AG Major Business
Table 67. Novartis AG Next-Generation Immunology Drugs Product and Services
Table 68. Novartis AG Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Novartis AG Recent Developments/Updates
Table 70. Novartis AG Competitive Strengths & Weaknesses
Table 71. Astellas Pharma Inc. Basic Information, Area Served and Competitors
Table 72. Astellas Pharma Inc. Major Business
Table 73. Astellas Pharma Inc. Next-Generation Immunology Drugs Product and Services
Table 74. Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Astellas Pharma Inc. Recent Developments/Updates
Table 76. Astellas Pharma Inc. Competitive Strengths & Weaknesses
Table 77. Bristol-Myers Squibb Company Basic Information, Area Served and Competitors
Table 78. Bristol-Myers Squibb Company Major Business
Table 79. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product and Services
Table 80. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Bristol-Myers Squibb Company Recent Developments/Updates
Table 82. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 83. Merck & Co., Inc. Basic Information, Area Served and Competitors
Table 84. Merck & Co., Inc. Major Business
Table 85. Merck & Co., Inc. Next-Generation Immunology Drugs Product and Services
Table 86. Merck & Co., Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Merck & Co., Inc. Recent Developments/Updates
Table 88. Eli Lilly and Company Basic Information, Area Served and Competitors
Table 89. Eli Lilly and Company Major Business
Table 90. Eli Lilly and Company Next-Generation Immunology Drugs Product and Services
Table 91. Eli Lilly and Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Next-Generation Immunology Drugs Upstream (Raw Materials)
Table 93. Next-Generation Immunology Drugs Typical Customers
LIST OF FIGURES
Figure 1. Next-Generation Immunology Drugs Picture
Figure 2. World Next-Generation Immunology Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Next-Generation Immunology Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Next-Generation Immunology Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Next-Generation Immunology Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Next-Generation Immunology Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Next-Generation Immunology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Next-Generation Immunology Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Next-Generation Immunology Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Next-Generation Immunology Drugs Markets in 2022
Figure 27. United States VS China: Next-Generation Immunology Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Next-Generation Immunology Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Next-Generation Immunology Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Next-Generation Immunology Drugs Market Size Market Share by Type in 2022
Figure 31. Cell Therapy
Figure 32. Small Molecule Drug
Figure 33. Others
Figure 34. World Next-Generation Immunology Drugs Market Size Market Share by Type (2018-2029)
Figure 35. World Next-Generation Immunology Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Next-Generation Immunology Drugs Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Clinic
Figure 39. Others
Figure 40. Next-Generation Immunology Drugs Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Next-Generation Immunology Drugs Picture
Figure 2. World Next-Generation Immunology Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Next-Generation Immunology Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Next-Generation Immunology Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Next-Generation Immunology Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Next-Generation Immunology Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Next-Generation Immunology Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Next-Generation Immunology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Next-Generation Immunology Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Next-Generation Immunology Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Next-Generation Immunology Drugs Markets in 2022
Figure 27. United States VS China: Next-Generation Immunology Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Next-Generation Immunology Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Next-Generation Immunology Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Next-Generation Immunology Drugs Market Size Market Share by Type in 2022
Figure 31. Cell Therapy
Figure 32. Small Molecule Drug
Figure 33. Others
Figure 34. World Next-Generation Immunology Drugs Market Size Market Share by Type (2018-2029)
Figure 35. World Next-Generation Immunology Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Next-Generation Immunology Drugs Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Clinic
Figure 39. Others
Figure 40. Next-Generation Immunology Drugs Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
